Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ishares Tr0 3 MTH TREASURY 0-3 MTH TREASURY | 0 | 700,000 | +700,000 | $0 | $70.48M | 48.33% | +$70.48M |
| Spdr Series TrustST STR SP BIOT ST STR SP BIOT | 0 | 386,500 | +386,500 | $0 | $60.94M | 41.79% | +$60.94M |
| Sera Prognostics IncCL A | 0 | 2,396,685 | +2,396,685 | $0 | $5.01M | 3.43% | +$5.01M |
| Halozyme Therapeutics, Inc.(HALO) | 0 | 3,000 | +3,000 | $0 | $331.2K | 0.23% | +$331.2K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 600 | +600 | $0 | $302.4K | 0.21% | +$302.4K |
| Exelixis, Inc.(EXEL) | 0 | 5,000 | +5,000 | $0 | $292.1K | 0.20% | +$292.1K |
| Royalty Pharma plcCL A(RPRX) | 0 | 5,000 | +5,000 | $0 | $291.8K | 0.20% | +$291.8K |
| argenx SEADR(ARGX) | 0 | 300 | +300 | $0 | $287.7K | 0.20% | +$287.7K |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 12,000 | +12,000 | $0 | $284.5K | 0.20% | +$284.5K |
| TG Therapeutics, Inc.(TGTX) | 0 | 5,000 | +5,000 | $0 | $278.9K | 0.19% | +$278.9K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 3,500 | +3,500 | $0 | $275.1K | 0.19% | +$275.1K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 0 | 7,000 | +7,000 | $0 | $274.8K | 0.19% | +$274.8K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 10,000 | +10,000 | $0 | $264.3K | 0.18% | +$264.3K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 3,500 | +3,500 | $0 | $261.1K | 0.18% | +$261.1K |
| Supernus Pharmaceuticals | 0 | 6,000 | +6,000 | $0 | $258.2K | 0.18% | +$258.2K |
| Immunome, Inc.(IMNM) | 0 | 12,000 | +12,000 | $0 | $258.1K | 0.18% | +$258.1K |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 1,800 | +1,800 | $0 | $255.3K | 0.18% | +$255.3K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 3,000 | +3,000 | $0 | $249.9K | 0.17% | +$249.9K |
| Tango Therapeutics, Inc.(TNGX) | 0 | 10,000 | +10,000 | $0 | $249.5K | 0.17% | +$249.5K |
| Definium Therapeutics, Inc.(DFTX) | 0 | 6,500 | +6,500 | $0 | $247.4K | 0.17% | +$247.4K |
| Revolution Medicines, Inc.(RVMD) | 0 | 1,200 | +1,200 | $0 | $246.3K | 0.17% | +$246.3K |
| Alkermes plcSHS(ALKS) | 0 | 6,000 | +6,000 | $0 | $243.1K | 0.17% | +$243.1K |
| Aurinia Pharmaceuticals Inc.(AUPH) | 0 | 15,000 | +15,000 | $0 | $242.9K | 0.17% | +$242.9K |
| Incyte Corporation(INCY) | 0 | 2,000 | +2,000 | $0 | $242.7K | 0.17% | +$242.7K |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 20,000 | +20,000 | $0 | $241.2K | 0.17% | +$241.2K |
| Immunovant, Inc.(IMVT) | 0 | 7,000 | +7,000 | $0 | $236.5K | 0.16% | +$236.5K |
| Stoke Therapeutics, Inc.(STOK) | 0 | 9,000 | +9,000 | $0 | $234.0K | 0.16% | +$234.0K |
| Krystal Biotech, Inc.(KRYS) | 0 | 692 | +692 | $0 | $230.1K | 0.16% | +$230.1K |
| Ascendis Pharma A/S(ASND) | 0 | 1,000 | +1,000 | $0 | $227.8K | 0.16% | +$227.8K |
| Syndax Pharmaceuticals Inc | 0 | 12,000 | +12,000 | $0 | $225.6K | 0.15% | +$225.6K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 2,000 | +2,000 | $0 | $223.6K | 0.15% | +$223.6K |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 2,500 | +2,500 | $0 | $220.1K | 0.15% | +$220.1K |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 15,000 | +15,000 | $0 | $214.8K | 0.15% | +$214.8K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 2,500 | +2,500 | $0 | $213.7K | 0.15% | +$213.7K |
| Immunocore Holdings plcADS(IMCR) | 0 | 7,000 | +7,000 | $0 | $212.0K | 0.15% | +$212.0K |
| Protagonist Therapeutics Inc | 0 | 1,500 | +1,500 | $0 | $211.3K | 0.14% | +$211.3K |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 5,000 | +5,000 | $0 | $203.0K | 0.14% | +$203.0K |
| Oric Pharmaceuticals Inc | 0 | 13,000 | +13,000 | $0 | $175.1K | 0.12% | +$175.1K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 10,000 | +10,000 | $0 | $161.1K | 0.11% | +$161.1K |
| COMPASS Pathways plcADS(CMPS) | 0 | 10,000 | +10,000 | $0 | $124.4K | 0.09% | +$124.4K |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 15,000 | +15,000 | $0 | $115.0K | 0.08% | +$115.0K |
| Cytomx Therapeutics Inc. | 0 | 39,400 | +39,400 | $0 | $107.2K | 0.07% | +$107.2K |
| Ardelyx Inc | 0 | 30,000 | +30,000 | $0 | $102.6K | 0.07% | +$102.6K |
| Olema Pharmaceuticals Inc | 0 | 10,000 | +10,000 | $0 | $86.4K | 0.06% | +$86.4K |